Zhang Xiangying, Gao Haotian, Qi Yifei, Li Yan, Wang Renxiao
Department of Medicinal Chemistry, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai 201203, China.
Molecules. 2024 Dec 24;30(1):18. doi: 10.3390/molecules30010018.
As an appealing approach for discovering novel leads, the key advantage of de novo drug design lies in its ability to explore a much broader dimension of chemical space, without being confined to the knowledge of existing compounds. So far, many generative models have been described in the literature, which have completely redefined the concept of de novo drug design. However, many of them lack practical value for real-world drug discovery. In this work, we have developed a graph-based generative model within a reinforcement learning framework, namely, METEOR (Molecular Exploration Through multiplE-Objective Reinforcement). The backend agent of METEOR is based on the well-established GCPN model. To ensure the overall quality of the generated molecular graphs, we implemented a set of rules to identify and exclude undesired substructures. Importantly, METEOR is designed to conduct multi-objective optimization, i.e., simultaneously optimizing binding affinity, drug-likeness, and synthetic accessibility of the generated molecules under the guidance of a special reward function. We demonstrate in a specific test case that without prior knowledge of true binders to the chosen target protein, METEOR generated molecules with superior properties compared to those in the ZINC 250k data set. In conclusion, we have demonstrated the potential of METEOR as a practical tool for generating rational drug-like molecules in the early phase of drug discovery.
作为一种发现新型先导化合物的有吸引力的方法,从头药物设计的关键优势在于其能够探索更广阔的化学空间维度,而不受限于现有化合物的知识。到目前为止,文献中已经描述了许多生成模型,它们完全重新定义了从头药物设计的概念。然而,其中许多模型对于实际的药物发现缺乏实用价值。在这项工作中,我们在强化学习框架内开发了一种基于图的生成模型,即METEOR(通过多目标强化进行分子探索)。METEOR的后端智能体基于成熟的GCPN模型。为了确保生成的分子图的整体质量,我们实施了一组规则来识别和排除不需要的子结构。重要的是,METEOR旨在进行多目标优化,即在特殊奖励函数的指导下,同时优化生成分子的结合亲和力、类药性和合成可及性。我们在一个特定的测试案例中证明,在没有关于所选靶蛋白真实结合剂的先验知识的情况下,METEOR生成的分子具有比ZINC 250k数据集中的分子更优异的性质。总之,我们已经证明了METEOR作为在药物发现早期生成合理的类药物分子的实用工具的潜力。